Evidence map›Paper›PMID 39079070›Full record

ArticleNeurology2024

Clinicopathologic and Neuroimaging Correlations of Nonverbal Oral Apraxia in Patients With Neurodegenerative Disease.

Danna P Garcia-Guaqueta, Hugo Botha, Rene L Utianski, Joseph R Duffy, Heather Clark, Gabriela Meade, Mary M Machulda, Dennis W Dickson, Nha Trang Thu Pham, Jennifer L Whitwell and 1 more

Abstract read
In one paragraph

Article in Neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Danna P Garcia-GuaquetaFrom the Department of Neurology (D.P.G.-G., H.B., R.L.U., J.R.D., H.C., G.M., K.A.J.), and Department of Psychiatry and Psychology (M.M.M.), Mayo Clinic, Rochester, MN; Department of Neuroscience (Neuropathology) (D.W.D.), Mayo Clinic, Jacksonville, FL; and Department of Radiology (N.T.T.P., J.L.W.), Mayo Clinic, Rochester, MN.ORCID 0000-0002-3565-3971
Hugo BothaFrom the Department of Neurology (D.P.G.-G., H.B., R.L.U., J.R.D., H.C., G.M., K.A.J.), and Department of Psychiatry and Psychology (M.M.M.), Mayo Clinic, Rochester, MN; Department of Neuroscience (Neuropathology) (D.W.D.), Mayo Clinic, Jacksonville, FL; and Department of Radiology (N.T.T.P., J.L.W.), Mayo Clinic, Rochester, MN.ORCID 0000-0003-4390-685X
Rene L UtianskiFrom the Department of Neurology (D.P.G.-G., H.B., R.L.U., J.R.D., H.C., G.M., K.A.J.), and Department of Psychiatry and Psychology (M.M.M.), Mayo Clinic, Rochester, MN; Department of Neuroscience (Neuropathology) (D.W.D.), Mayo Clinic, Jacksonville, FL; and Department of Radiology (N.T.T.P., J.L.W.), Mayo Clinic, Rochester, MN.ORCID 0000-0001-9519-1302
Joseph R DuffyFrom the Department of Neurology (D.P.G.-G., H.B., R.L.U., J.R.D., H.C., G.M., K.A.J.), and Department of Psychiatry and Psychology (M.M.M.), Mayo Clinic, Rochester, MN; Department of Neuroscience (Neuropathology) (D.W.D.), Mayo Clinic, Jacksonville, FL; and Department of Radiology (N.T.T.P., J.L.W.), Mayo Clinic, Rochester, MN.ORCID 0000-0001-8206-3432
Heather ClarkFrom the Department of Neurology (D.P.G.-G., H.B., R.L.U., J.R.D., H.C., G.M., K.A.J.), and Department of Psychiatry and Psychology (M.M.M.), Mayo Clinic, Rochester, MN; Department of Neuroscience (Neuropathology) (D.W.D.), Mayo Clinic, Jacksonville, FL; and Department of Radiology (N.T.T.P., J.L.W.), Mayo Clinic, Rochester, MN.ORCID 0000-0001-9697-0084
Gabriela MeadeFrom the Department of Neurology (D.P.G.-G., H.B., R.L.U., J.R.D., H.C., G.M., K.A.J.), and Department of Psychiatry and Psychology (M.M.M.), Mayo Clinic, Rochester, MN; Department of Neuroscience (Neuropathology) (D.W.D.), Mayo Clinic, Jacksonville, FL; and Department of Radiology (N.T.T.P., J.L.W.), Mayo Clinic, Rochester, MN.ORCID 0000-0001-6153-7782
Mary M MachuldaFrom the Department of Neurology (D.P.G.-G., H.B., R.L.U., J.R.D., H.C., G.M., K.A.J.), and Department of Psychiatry and Psychology (M.M.M.), Mayo Clinic, Rochester, MN; Department of Neuroscience (Neuropathology) (D.W.D.), Mayo Clinic, Jacksonville, FL; and Department of Radiology (N.T.T.P., J.L.W.), Mayo Clinic, Rochester, MN.ORCID 0000-0003-4834-5967
Dennis W DicksonFrom the Department of Neurology (D.P.G.-G., H.B., R.L.U., J.R.D., H.C., G.M., K.A.J.), and Department of Psychiatry and Psychology (M.M.M.), Mayo Clinic, Rochester, MN; Department of Neuroscience (Neuropathology) (D.W.D.), Mayo Clinic, Jacksonville, FL; and Department of Radiology (N.T.T.P., J.L.W.), Mayo Clinic, Rochester, MN.ORCID 0000-0001-7189-7917
Nha Trang Thu PhamFrom the Department of Neurology (D.P.G.-G., H.B., R.L.U., J.R.D., H.C., G.M., K.A.J.), and Department of Psychiatry and Psychology (M.M.M.), Mayo Clinic, Rochester, MN; Department of Neuroscience (Neuropathology) (D.W.D.), Mayo Clinic, Jacksonville, FL; and Department of Radiology (N.T.T.P., J.L.W.), Mayo Clinic, Rochester, MN.
Jennifer L WhitwellFrom the Department of Neurology (D.P.G.-G., H.B., R.L.U., J.R.D., H.C., G.M., K.A.J.), and Department of Psychiatry and Psychology (M.M.M.), Mayo Clinic, Rochester, MN; Department of Neuroscience (Neuropathology) (D.W.D.), Mayo Clinic, Jacksonville, FL; and Department of Radiology (N.T.T.P., J.L.W.), Mayo Clinic, Rochester, MN.ORCID 0000-0001-6914-1563
Keith A JosephsFrom the Department of Neurology (D.P.G.-G., H.B., R.L.U., J.R.D., H.C., G.M., K.A.J.), and Department of Psychiatry and Psychology (M.M.M.), Mayo Clinic, Rochester, MN; Department of Neuroscience (Neuropathology) (D.W.D.), Mayo Clinic, Jacksonville, FL; and Department of Radiology (N.T.T.P., J.L.W.), Mayo Clinic, Rochester, MN.ORCID 0000-0003-2930-8634

Funding

Longitudinal multi-modality imaging in progressive apraxia of speech (Diversity Supplement)R01DC012519 · NIDCD · MAYO CLINIC ROCHESTER · PI Jennifer Louise Whitwell · 2013 to 2026
$7.2M
The neurobiology of two distinct types of progressive apraxia of speechR01DC014942 · NIDCD · MAYO CLINIC ROCHESTER · PI Keith A Josephs, Rene Lynn Utianski · 2017 to 2026
$4.9M
NIDCD NIH HHS R01 DC012519NIDCD NIH HHS R01 DC014942
6 · The paper itself

Abstract

BACKGROUND AND

objectivesNonverbal oral apraxia (NVOA) is the inability to plan, sequence, and execute voluntary oromotor movements in the absence of weakness. In the context of neurodegenerative disease, it remains unclear whether it is linked to a specific underlying pathologic, clinical, or neuroimaging finding. Thus, we aimed to assess the clinicopathologic and neuroimaging associations of NVOA.

methodsWe conducted a retrospective study of autopsy-confirmed patients previously assessed through an NVOA evaluation tool with a previously published cutpoint to screen for NVOA. We compared demographic and clinical characteristics and postmortem pathology between those who developed NVOA and those who did not. We also compared clinicopathologic characteristics in mild vs greater than mild NVOA and early vs late-emerging NVOA. SPM12 was used to assess patterns of gray matter loss in NVOA vs non-NVOA with age and sex included as covariates.

resultsA total of 104 patients (median age at symptom onset 63 years, 43% female) were included in the study. 63 (60.6%) developed NVOA. NVOA appeared at a median of 4.3 years from symptom onset. 29% developed NVOA within the first 3 years. Primary progressive apraxia of speech and the nonfluent variant of primary progressive aphasia were the most common baseline diagnoses in the NVOA group while progressive supranuclear palsy (PSP) syndrome and logopenic progressive aphasia (LPA) were the most common in patients without NVOA. Atrophy of the left lateral and medial posterior frontal cortex was related to NVOA. The most common pathologies associated with NVOA were PSP (36.5%) and corticobasal degeneration (CBD) (33.3%). In patients without NVOA, PSP (26.8%) and other pathologies (26.8%) were the most frequent. 11% of patients with NVOA had persistently mild NVOA and were more likely to have baseline diagnoses of LPA, PSP syndrome, or semantic dementia. The most frequent pathologies in this group were Alzheimer disease and PSP. The pathologic associations of greater than mild NVOA were CBD and PSP. DISCUSSION: NVOA is present in several clinical syndromes. It is most associated with PSP and CBD. NVOA is a manifestation of left lateral and medial posterior frontal cortex damage rather than a particular pathology.

Indexed as

ApraxiasNeurodegenerative DiseasesNeuroimagingAgedBrainFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedRetrospective StudiesSupranuclear Palsy, Progressive

Identifiers

PMID39079070
PMCPMC11286287

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.